These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31188740)

  • 1. Contribution of astrocytes to metabolic dysfunction in the Alzheimer's disease brain.
    Zulfiqar S; Garg P; Nieweg K
    Biol Chem; 2019 Aug; 400(9):1113-1127. PubMed ID: 31188740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.
    Dorey E; Bamji-Mirza M; Najem D; Li Y; Liu H; Callaghan D; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Alzheimers Dis; 2017; 57(4):1265-1279. PubMed ID: 28372324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte and Alzheimer's disease.
    Cai Z; Wan CQ; Liu Z
    J Neurol; 2017 Oct; 264(10):2068-2074. PubMed ID: 28821953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective.
    Suidan GL; Ramaswamy G
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study.
    Shao Y; Gearing M; Mirra SS
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):376-81. PubMed ID: 9100668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
    Schultz B; Taday J; Menezes L; Cigerce A; Leite MC; Gonçalves CA
    J Alzheimers Dis; 2021; 84(4):1415-1430. PubMed ID: 34719501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.
    Vincent B; Smith JD
    Eur J Neurosci; 2001 Jul; 14(2):256-66. PubMed ID: 11553277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of astrocytic glycolytic metabolism in Alzheimer's disease pathogenesis.
    Fu W; Jhamandas JH
    Biogerontology; 2014 Dec; 15(6):579-86. PubMed ID: 25106114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes.
    Arélin K; Kinoshita A; Whelan CM; Irizarry MC; Rebeck GW; Strickland DK; Hyman BT
    Brain Res Mol Brain Res; 2002 Jul; 104(1):38-46. PubMed ID: 12117549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes.
    Komai M; Noda Y; Ikeda A; Kaneshiro N; Kamikubo Y; Sakurai T; Uehara T; Takasugi N
    J Lipid Res; 2024 Mar; 65(3):100510. PubMed ID: 38280459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of astrocytes to Alzheimer's disease.
    Birch AM
    Biochem Soc Trans; 2014 Oct; 42(5):1316-20. PubMed ID: 25233409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of amyloid-beta with ApoE.
    Carter DB
    Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.
    Allaman I; Gavillet M; Bélanger M; Laroche T; Viertl D; Lashuel HA; Magistretti PJ
    J Neurosci; 2010 Mar; 30(9):3326-38. PubMed ID: 20203192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.